Loading…

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production

Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participa...

Full description

Saved in:
Bibliographic Details
Published in:Toxins 2023-09, Vol.15 (10), p.589
Main Authors: Miranda, Ana Luísa Soares de, Antunes, Bruno Cesar, Minozzo, João Carlos, Lima, Sabrina de Almeida, Botelho, Ana Flávia Machado, Campos, Marco Túlio Gomes, Chávez-Olórtegui, Carlos, Soto-Blanco, Benito
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273
container_end_page
container_issue 10
container_start_page 589
container_title Toxins
container_volume 15
creator Miranda, Ana Luísa Soares de
Antunes, Bruno Cesar
Minozzo, João Carlos
Lima, Sabrina de Almeida
Botelho, Ana Flávia Machado
Campos, Marco Túlio Gomes
Chávez-Olórtegui, Carlos
Soto-Blanco, Benito
description Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.
doi_str_mv 10.3390/toxins15100589
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a5936d33c0584bc7b25bb11666c1984e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A772533890</galeid><doaj_id>oai_doaj_org_article_a5936d33c0584bc7b25bb11666c1984e</doaj_id><sourcerecordid>A772533890</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273</originalsourceid><addsrcrecordid>eNptkk1vGyEQhldVqyZyc-2xQuqlF6cDLCx7qiIrrSNZaqUkZ8TyYWPtLi6wkfPvi5M0javAgWF45mVmNFX1EcM5pS18zWHvx4QZBmCifVOdEmjInHOG376wT6qzlLZQFqW4xc376oQ2QghO4LQyNxuLllb1eYOus8pTQsGhZYjJJnSbrEEuRKQyWlmVMrr2e7QIw6632aLFve7tA78K-5C07b1GF2P2d3YMA_oVg5l09mH8UL1zqk_27OmcVbffL28Wy_nq54-rxcVqrhk0ed7yrhPO1QoLymsKQIB0qsbCCUcxtKVkJkAwqgF3gA13hxsYYThzhjR0Vl096pqgtnIX_aDivQzKywdHiGupYvYla6lYS7mhRYqJutNNR1jXYcw517gVtS1a3x61dlM3WKPtmKPqj0SPX0a_ketwJzHwkmvJclZ9eVKI4fdkU5aDPzSpV6MNU5JECMoaaDAp6Of_0G2Y4lh6daCIqIG39T9qrUoFfnShfKwPovKiaQijVLRQqPNXqLKNHbwOo3W--F8L0DGkFK17LhKDPMyZPJ6zEvDpZWue8b9TRf8AM0jLmg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2882840694</pqid></control><display><type>article</type><title>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central(OpenAccess)</source><creator>Miranda, Ana Luísa Soares de ; Antunes, Bruno Cesar ; Minozzo, João Carlos ; Lima, Sabrina de Almeida ; Botelho, Ana Flávia Machado ; Campos, Marco Túlio Gomes ; Chávez-Olórtegui, Carlos ; Soto-Blanco, Benito</creator><creatorcontrib>Miranda, Ana Luísa Soares de ; Antunes, Bruno Cesar ; Minozzo, João Carlos ; Lima, Sabrina de Almeida ; Botelho, Ana Flávia Machado ; Campos, Marco Túlio Gomes ; Chávez-Olórtegui, Carlos ; Soto-Blanco, Benito</creatorcontrib><description>Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.</description><identifier>ISSN: 2072-6651</identifier><identifier>EISSN: 2072-6651</identifier><identifier>DOI: 10.3390/toxins15100589</identifier><identifier>PMID: 37888620</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Abnormalities ; Abscesses ; Adjuvants, Immunologic ; Animal experimentation ; Animal welfare ; Animals ; Antigens ; antisera production ; Antivenins ; Antivenom ; brown spider ; Cardiac arrhythmia ; Clinical significance ; dermonecrosis ; Design and construction ; EKG ; Health aspects ; Health Status ; Heart ; Hematology ; Horses ; Immunization ; Immunoglobulins ; Inoculation ; Liver ; loxoscelism ; Lymphatic system ; Methods ; Pacemakers ; Physiology ; Renal function ; safety evaluation ; Sinuses ; Statistical significance ; Testing ; Venom</subject><ispartof>Toxins, 2023-09, Vol.15 (10), p.589</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273</cites><orcidid>0000-0001-6247-2255 ; 0000-0003-0341-114X ; 0000-0003-2521-1114 ; 0000-0003-3861-1838 ; 0000-0003-4837-9374</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2882840694/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2882840694?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37888620$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miranda, Ana Luísa Soares de</creatorcontrib><creatorcontrib>Antunes, Bruno Cesar</creatorcontrib><creatorcontrib>Minozzo, João Carlos</creatorcontrib><creatorcontrib>Lima, Sabrina de Almeida</creatorcontrib><creatorcontrib>Botelho, Ana Flávia Machado</creatorcontrib><creatorcontrib>Campos, Marco Túlio Gomes</creatorcontrib><creatorcontrib>Chávez-Olórtegui, Carlos</creatorcontrib><creatorcontrib>Soto-Blanco, Benito</creatorcontrib><title>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</title><title>Toxins</title><addtitle>Toxins (Basel)</addtitle><description>Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.</description><subject>Abnormalities</subject><subject>Abscesses</subject><subject>Adjuvants, Immunologic</subject><subject>Animal experimentation</subject><subject>Animal welfare</subject><subject>Animals</subject><subject>Antigens</subject><subject>antisera production</subject><subject>Antivenins</subject><subject>Antivenom</subject><subject>brown spider</subject><subject>Cardiac arrhythmia</subject><subject>Clinical significance</subject><subject>dermonecrosis</subject><subject>Design and construction</subject><subject>EKG</subject><subject>Health aspects</subject><subject>Health Status</subject><subject>Heart</subject><subject>Hematology</subject><subject>Horses</subject><subject>Immunization</subject><subject>Immunoglobulins</subject><subject>Inoculation</subject><subject>Liver</subject><subject>loxoscelism</subject><subject>Lymphatic system</subject><subject>Methods</subject><subject>Pacemakers</subject><subject>Physiology</subject><subject>Renal function</subject><subject>safety evaluation</subject><subject>Sinuses</subject><subject>Statistical significance</subject><subject>Testing</subject><subject>Venom</subject><issn>2072-6651</issn><issn>2072-6651</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vGyEQhldVqyZyc-2xQuqlF6cDLCx7qiIrrSNZaqUkZ8TyYWPtLi6wkfPvi5M0javAgWF45mVmNFX1EcM5pS18zWHvx4QZBmCifVOdEmjInHOG376wT6qzlLZQFqW4xc376oQ2QghO4LQyNxuLllb1eYOus8pTQsGhZYjJJnSbrEEuRKQyWlmVMrr2e7QIw6632aLFve7tA78K-5C07b1GF2P2d3YMA_oVg5l09mH8UL1zqk_27OmcVbffL28Wy_nq54-rxcVqrhk0ed7yrhPO1QoLymsKQIB0qsbCCUcxtKVkJkAwqgF3gA13hxsYYThzhjR0Vl096pqgtnIX_aDivQzKywdHiGupYvYla6lYS7mhRYqJutNNR1jXYcw517gVtS1a3x61dlM3WKPtmKPqj0SPX0a_ketwJzHwkmvJclZ9eVKI4fdkU5aDPzSpV6MNU5JECMoaaDAp6Of_0G2Y4lh6daCIqIG39T9qrUoFfnShfKwPovKiaQijVLRQqPNXqLKNHbwOo3W--F8L0DGkFK17LhKDPMyZPJ6zEvDpZWue8b9TRf8AM0jLmg</recordid><startdate>20230926</startdate><enddate>20230926</enddate><creator>Miranda, Ana Luísa Soares de</creator><creator>Antunes, Bruno Cesar</creator><creator>Minozzo, João Carlos</creator><creator>Lima, Sabrina de Almeida</creator><creator>Botelho, Ana Flávia Machado</creator><creator>Campos, Marco Túlio Gomes</creator><creator>Chávez-Olórtegui, Carlos</creator><creator>Soto-Blanco, Benito</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6247-2255</orcidid><orcidid>https://orcid.org/0000-0003-0341-114X</orcidid><orcidid>https://orcid.org/0000-0003-2521-1114</orcidid><orcidid>https://orcid.org/0000-0003-3861-1838</orcidid><orcidid>https://orcid.org/0000-0003-4837-9374</orcidid></search><sort><creationdate>20230926</creationdate><title>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</title><author>Miranda, Ana Luísa Soares de ; Antunes, Bruno Cesar ; Minozzo, João Carlos ; Lima, Sabrina de Almeida ; Botelho, Ana Flávia Machado ; Campos, Marco Túlio Gomes ; Chávez-Olórtegui, Carlos ; Soto-Blanco, Benito</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abnormalities</topic><topic>Abscesses</topic><topic>Adjuvants, Immunologic</topic><topic>Animal experimentation</topic><topic>Animal welfare</topic><topic>Animals</topic><topic>Antigens</topic><topic>antisera production</topic><topic>Antivenins</topic><topic>Antivenom</topic><topic>brown spider</topic><topic>Cardiac arrhythmia</topic><topic>Clinical significance</topic><topic>dermonecrosis</topic><topic>Design and construction</topic><topic>EKG</topic><topic>Health aspects</topic><topic>Health Status</topic><topic>Heart</topic><topic>Hematology</topic><topic>Horses</topic><topic>Immunization</topic><topic>Immunoglobulins</topic><topic>Inoculation</topic><topic>Liver</topic><topic>loxoscelism</topic><topic>Lymphatic system</topic><topic>Methods</topic><topic>Pacemakers</topic><topic>Physiology</topic><topic>Renal function</topic><topic>safety evaluation</topic><topic>Sinuses</topic><topic>Statistical significance</topic><topic>Testing</topic><topic>Venom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miranda, Ana Luísa Soares de</creatorcontrib><creatorcontrib>Antunes, Bruno Cesar</creatorcontrib><creatorcontrib>Minozzo, João Carlos</creatorcontrib><creatorcontrib>Lima, Sabrina de Almeida</creatorcontrib><creatorcontrib>Botelho, Ana Flávia Machado</creatorcontrib><creatorcontrib>Campos, Marco Túlio Gomes</creatorcontrib><creatorcontrib>Chávez-Olórtegui, Carlos</creatorcontrib><creatorcontrib>Soto-Blanco, Benito</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Toxins</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miranda, Ana Luísa Soares de</au><au>Antunes, Bruno Cesar</au><au>Minozzo, João Carlos</au><au>Lima, Sabrina de Almeida</au><au>Botelho, Ana Flávia Machado</au><au>Campos, Marco Túlio Gomes</au><au>Chávez-Olórtegui, Carlos</au><au>Soto-Blanco, Benito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production</atitle><jtitle>Toxins</jtitle><addtitle>Toxins (Basel)</addtitle><date>2023-09-26</date><risdate>2023</risdate><volume>15</volume><issue>10</issue><spage>589</spage><pages>589-</pages><issn>2072-6651</issn><eissn>2072-6651</eissn><abstract>Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were used and established as the immunized group (IG). Under the same handling and general management, eleven horses were established as the control group (CG). The horses were evaluated regarding their general clinical status and had their blood sampled, and an ECG recorded. The IG presented lower RBC and PCV, despite keeping values within inferior limits for the species. Renal function was not impaired, and liver-related enzymes were higher than those in the CG, probably due to liver exertion from immunoglobulin synthesis. ECG showed some abnormalities in the IG, such as atrioventricular block and a wandering atrial pacemaker, corroborated by an increase in CK-MB. The cardiovascular abnormalities were mainly found in the horses that participated in several antivenom-producing cycles. The overall results indicate that these horses had some impairment of their general health status. Once available, some alternative, less toxic antigens should replace the venom for immunization of horses used for antivenom production.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37888620</pmid><doi>10.3390/toxins15100589</doi><orcidid>https://orcid.org/0000-0001-6247-2255</orcidid><orcidid>https://orcid.org/0000-0003-0341-114X</orcidid><orcidid>https://orcid.org/0000-0003-2521-1114</orcidid><orcidid>https://orcid.org/0000-0003-3861-1838</orcidid><orcidid>https://orcid.org/0000-0003-4837-9374</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6651
ispartof Toxins, 2023-09, Vol.15 (10), p.589
issn 2072-6651
2072-6651
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a5936d33c0584bc7b25bb11666c1984e
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central(OpenAccess)
subjects Abnormalities
Abscesses
Adjuvants, Immunologic
Animal experimentation
Animal welfare
Animals
Antigens
antisera production
Antivenins
Antivenom
brown spider
Cardiac arrhythmia
Clinical significance
dermonecrosis
Design and construction
EKG
Health aspects
Health Status
Heart
Hematology
Horses
Immunization
Immunoglobulins
Inoculation
Liver
loxoscelism
Lymphatic system
Methods
Pacemakers
Physiology
Renal function
safety evaluation
Sinuses
Statistical significance
Testing
Venom
title The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A12%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Health%20Status%20of%20Horses%20Used%20for%20at%20Least%20Six%20Complete%20Cycles%20of%20Loxoscelic%20Antivenom%20Production&rft.jtitle=Toxins&rft.au=Miranda,%20Ana%20Lu%C3%ADsa%20Soares%20de&rft.date=2023-09-26&rft.volume=15&rft.issue=10&rft.spage=589&rft.pages=589-&rft.issn=2072-6651&rft.eissn=2072-6651&rft_id=info:doi/10.3390/toxins15100589&rft_dat=%3Cgale_doaj_%3EA772533890%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-96bb8ff4a18364300202ba418f8f3109390580853c01b01d6f80850d8d65fd273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2882840694&rft_id=info:pmid/37888620&rft_galeid=A772533890&rfr_iscdi=true